This process protects from accumulation of Aβ and the subsequent development of Alzheimer’s disease or other age-related diseases [52]; hence, NEP inhibitors may play a detrimental role in this case. The gene discussed is MME; the disease is early-onset autosomal dominant Alzheimer disease.